Biotech and pharmaceutical companies operate at the intersection of innovation, regulation, and capital markets. From early-stage development to commercialization, these businesses face high burn rates, complex clinical pathways, and the pressure of investor scrutiny. Strategic clarity and operational rigor are essential to long-term success.
